Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

4. PSICOFARMACOLOGÍA DE LA DEPENDENCIA DE LAS DIFERENTES CLASES DE DROGASBrownstein MJ (1993) A brief history of opiates, opioid peptides and opioidreceptors. Proceedings of the National Academy of Science of the United States ofAmerica, 90:5391–5393.Butschky MF y colab. (1995) Smoking without nicotine delivery decreases withdrawalin 12-hour abstinent smokers. Pharmacology, Biochemistry and Behavior,50:91–96.Byrne A y colab. (1991) Psychiatric and neurological effects of chronic solventabuse. Canadian Journal of Psychiatry, 36:735–738.Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists oncocaine self-administration under different schedules of reinforcement in the rat.Journal of Pharmacology and Experimental Therapeutics, 270:209–218.Cami J y colab. (1997) Pharmacokinetics of Ecstasy (MDMA) in healthy subjects.En: 2o. Congreso de la Asociación Europea de Farmacología Clínica y Terapéutica,Berlín, Alemania, 1997. European Journal of Clinical Pharmacology, 52:168.Carboni E y colab. (1989) Amphetamine, cocaine, phencyclidine and nomifensineincrease extracellular dopamine concentrations preferentially in the nucleusaccumbens of freely- moving rats. Neuroscience, 28:653–661.Carden SE, Coons EE (1990) Diazepam's impact on self-stimulation but not stimulation-escapesuggests hedonic modulation. Behavioral Neuroscience, 104:56–61.Chen JP y colab. (1990) Delta 9-tetrahydrocannabinol produces naloxoneblockableenhancement of presynaptic basal dopamine efflux in nucleus accumbensof conscious, freely-moving rats as measured by intracerebral microdialysis.Psychopharmacology, 102:156–162.Clarke PBS, Pert A (1985) Autoradiographic evidence for nicotine receptors onnigrostriatal and mesolimbic dopaminergic projections. Brain Research,348:355¯358.Collier HO (1980) Cellular site of opiate dependence. Nature, 283:625–629.Collins AC, Marks MJ (1989) Chronic nicotine exposure and brain nicotinicreceptors: influence of genetic factors. Progress in Brain Research, 79:137-46.Corrigall WA (1999) Nicotine self-administration in animals as a dependencemodel. Nicotine and Tobacco Research, 1:11–20.Corringer PJ, Le Novere N, Changeux JP (2000) Nicotinic receptors at theamino acid level. Annual Review of Pharmacology and Toxicology, 40:431–458.Dani JÁ, De Biasi M (2001) Cellular mechanisms of nicotine addiction.Pharmacology, Biochemistry and Behavior, 70:439–446.Davis WM, Smith TE, Smith SG (1987) Intravenous and intragastric self-administrationof chlordiazepoxide in the rat. Alcohol and Drug Research, 7:511–516.De la Torre R y colab. (2000) Non-linear pharmacokinetics of MDMA(‘Ecstasy’) in humans. British Journal of Clinical Pharmacology, 49:104–109.Devane WA y colab. (1988) Determination and characterization of cannabinoidreceptor in rat brain. Molecular Pharmacology, 34:605–613.Devane WA y colab. (1992) Isolation and structure of a brain constituent thatbinds to the cannabinoid receptor. Science, 258:1946–1949.111
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASDi Chiara G (2000) Role of dopamine in the behavioural actions of nicotinerelated to addiction. European Journal of Pharmacology, 393:295–314.Di Chiara G, Imperato A (1988a) Drug abuse by humans preferentially increasessynaptic dopamine concentrations in the mesolimbic system of freely-movingrats. Proceedings of the National Academy of Science of the United States of America,94:5274–5278.Di Chiara G, Imperato A (1988b) Opposite effects of mu- and kappa-opiate agonistson dopamine release in the nucleus accumbens and in the dorsal caudate of freelymovingrats. Journal of Pharmacology and Experimental Therapeutics, 244:1067–1080.Di Marzo V (1999) Biosynthesis and inactivation of endocannabinoids: relevanceto their proposed role as neuromodulators. Life Sciences, 65:645–655.Di Marzo V y colab. (1998) Endocannabinoids: endogenous cannabinoid receptorligands with neuromodulatory action. Trends in Neuroscience, 21:521–528.Downing J (1986) The psychological and physiological effects of MDMA onnormal volunteers. Journal of Psychoactive Drugs, 18:335–340.Evans AC, Raistrick D (1987) Phenomenology of intoxication with toluenebasedadhesives and butane gas. British Journal of Psychiatry, 150:769–773.Evans EB, Balster RL (1991) CNS depressant effects of volatile organic solvents.Neuroscience and Biobehavioral Reviews, 15:233–241.Fadda F, Rossetti ZL (1998) Chronic ethanol consumption: from neuroadaptationto neurodegeneration. Progress in Neurobiology, 56:385–431.Farrell M y colab. (2002) Methamphetamine: drug use and psychoses becomesa major public health issue in the Asia-Pacific region. Addiction, 9:771–772.Feigenbaum JJ, Yanai J (1983) Evidence for the involvement of central dopaminergicreceptors in the acute and chronic effects induced by barbiturates.Neuropsychobiology, 9:83–87.Fischer B y colab. (2002) Heroin-assisted treatment as a response to the publichealth problem of opiate dependence in established market economies: anoverview. European Journal of Public Health, 12:228-34.Fischer G y colab. (2000) Treatment of opioid-dependent pregnant women withbuprenorphine. Addiction, 95:239–244.Foulds J y colab. (1997) Mood and physiological effects of subcutaneous nicotinein smokers and never-smokers. Drug and Alcohol Dependence, 44:105–115.Fowler JS y colab. (2001) [(11)] Cocaine: PET studies of cocaine pharmacokinetics,dopamine transporter availability and dopamine transporter occupancy.Nuclear Medicine and Biology, 28:561–572.Fox BS y colab. (1996) Efficacy of a therapeutic cocaine vaccine in rodent models.Nature Medicine, 2:1129–1132.French ED (1997) Delta 9-tetrahydrocannabinol excites rat VTA dopamine neuronsthrough activation of cannabinoid CB1 but not opioid receptors.Neuroscience Letters, 226:159–162.Galiegue S y colab. (1995) Expression of central and peripheral cannabinoidreceptors in human immune tissues and leukocyte subpopulations. EuropeanJournal of Biochemistry, 232:54–61.112
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 88 and 89: Capítulo 4Psicofarmacología de la
Page 90 and 91: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 146 and 147: Capítulo 5Bases Genéticas de lasF
Page 148 and 149: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 182 and 183:
5. BASES GENÉTICAS DE LAS FARMACOD
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Capítulo 6Trastornos ConcurrentesI
Page 192 and 193:
6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195:
6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197:
6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199:
6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201:
6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203:
6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205:
6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207:
6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209:
6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211:
6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213:
6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215:
6. TRASTORNOS CONCURRENTESCarol G y
Page 216 and 217:
6. TRASTORNOS CONCURRENTESdepressio
Page 218 and 219:
6. TRASTORNOS CONCURRENTESHall RG y
Page 220 and 221:
6. TRASTORNOS CONCURRENTESKapur S,
Page 222 and 223:
6. TRASTORNOS CONCURRENTESMansvelde
Page 224 and 225:
6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227:
6. TRASTORNOS CONCURRENTESSevy S y
Page 228:
6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

Create successful ePaper yourself

Delete template?

Save as template?